Indian benchmark indices fell on May 26, 2024, as selling pressure on the monthly expiry day drove markets lower [1, 2].
The downturn reflects investor caution and weak market breadth, signaling a shift in sentiment during a critical settlement period for traders.
The Sensex dropped more than 500 points and ended the session approximately 0.7% lower [1]. Earlier in the day, the index had fallen 300 points from its daily high [2], and was reported down 281 points at 1:07 p.m. [2].
Similarly, the Nifty experienced volatility throughout the session. While some reports indicated the index was trading near the 24,000 mark [2], it ultimately failed to sustain the 23,900 level [1].
Despite the general decline in the equity markets, the Pharma index stood out as the top sectoral gainer [1]. This divergence suggests that investors sought refuge in defensive sectors while exiting broader market positions.
Market analysts said the red close was due to the combined impact of the monthly expiry and a lack of positive momentum across most sectors [1, 2].
“The Sensex dropped more than 500 points and ended the session approximately 0.7% lower.”
The decline in the Sensex and Nifty during the May expiry highlights the sensitivity of Indian markets to derivatives settlement dates. The fact that the pharma sector gained while the broader market fell indicates a flight to safety, where investors rotate capital into defensive stocks to mitigate risks during periods of high volatility.
